Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus with low-dose cyclosporin and steroids after anti-CD25 induction in pediatric kidney transplant recipients
2008-006729-15Phase 2Active
- Sponsor
- Istituto Giannina Gaslini
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of everolimus in kidney allograft rejection and Kidney allograft status (RTx) (2 arms), sponsored by Istituto Giannina Gaslini. Primary endpoint: Failure rate. Started Dec 2008; status: active.
02
Drugs
everolimus
03
Conditions
kidney allograft rejectionKidney allograft status (RTx)
Beyond the preview
Go deeper on 2008-006729-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006729-15.